SCHEMBL8329637

SCHEMBL8329637

O=C(O[C@]1(C(=O)c2ccccc2)[C@@H](O)[C@@H](O)O[C@H](CO)[C@@H]1Cl)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
LGALS9 O00182 6/20 0.44
LGALS1 P09382 6/20 0.44
LGALS3 P17931 6/20 0.44
LGALS7; LGALS7B P47929 5/20 0.44
HK1 P19367 2/20 0.36
HK2 P52789 2/20 0.36
MAOB P27338 1/20 0.36
LGALS8 O00214 3/20 0.34
ALDH1A1 P00352 2/20 0.33
F2 P00734 1/20 0.32
LMNA P02545 1/20 0.32
RNASE1 P07998 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8369358 0.89 LGALS9 (0.43) LGALS9LGALS1LGALS3LGALS7; LGALS7BHK1
SCHEMBL28448343 0.71 HK1 (0.41) LGALS9LGALS1LGALS3LGALS7; LGALS7BHK1
SCHEMBL28448346 0.71 HK1 (0.41) LGALS9LGALS1LGALS3LGALS7; LGALS7BHK1
SCHEMBL2506762 0.71 LGALS3 (0.44) LGALS9LGALS1LGALS3LGALS7; LGALS7BLGALS8
SCHEMBL10392788 0.70 LMNA (0.44) ALDH1A1F2LMNA
SCHEMBL8369357 0.69 LGALS3 (0.47) LGALS9LGALS1LGALS3LGALS7; LGALS7BHK1
SCHEMBL7744292 0.68 LGALS3 (0.61) LGALS9LGALS1LGALS3LGALS7; LGALS7BHK1
SCHEMBL715283 0.68 LGALS3 (0.61) LGALS9LGALS1LGALS3LGALS7; LGALS7BHK1
SCHEMBL715284 0.68 LGALS3 (0.61) LGALS9LGALS1LGALS3LGALS7; LGALS7BHK1
SCHEMBL28268402 0.68 LGALS9 (0.45) LGALS9LGALS1LGALS3LGALS7; LGALS7BHK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997018222-A9 NOVEL OLIGOSACCHARIDE GLYCOSIDES HAVING MAMMALIAN IMMUNOSUPPRESSIVE AND TOLEROGENIC PROPERTIES GLYCOMED INC (US) 1999-07-01 WO disclosed